CDKN2B and esophageal squamous cell carcinoma: Knockdown of CDKN2B-AS1 increased the expression of p15 (INK4b) and transforming growth factor β1 (TGFβ1) resulting in the inhibition of cellular proliferation in human esophageal squamous cell carcinoma [42].